Medrogestone
Drug Approvals
(British Approved Name, US Adopted Name, rINN)
INNs in other languages (French, Latin, and Spanish):
Profile
Medrogestone is a progestogen structurally related to progesterone that is used in the treatment of menstrual disorders, and as the progestogen in menopausal HRT. It is usually given orally in daily doses of 5 to 10 mg, generally in a cyclical regimen. Higher doses were used in the treatment of endometrial carcinoma, prostatic hyperplasia, and breast disorders including carcinoma. It has also been used for threatened or recurrent miscarriage, but such use is not recommended unless there is proven progesterone deficiency.
Preparations
Proprietary Preparations
Austria: Colpron
Belgium: Colpro †
France: Colprone
Germany: Prothil
Hong Kong: Colprone †
Italy: Colprone †
South Africa: Colpro †
Spain: Colpro
Switzerland: Colpro
Multi-ingredient
Austria: Premarin compositum † Premarin Plus
Belgium: Premplus
Czech Republic: Presomen Compositum †
Germany: Presomen Compositum
Hong Kong: Prempak
Italy: Prempak †
Malaysia: Prempak
The Netherlands: Premarin Plus
Portugal: Premarin Plus
South Africa: Prempak
Switzerland: Premarin Plus
Posted in: Drugs
